{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:00:22Z","timestamp":1795143622563,"version":"4.10.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly & Company","doi-asserted-by":"publisher","award":["SRA5200886401"],"award-info":[{"award-number":["SRA5200886401"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS|National Institutes of Health","doi-asserted-by":"publisher","award":["CA192381"],"award-info":[{"award-number":["CA192381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS|National Institutes of Health","doi-asserted-by":"publisher","award":["CA210181"],"award-info":[{"award-number":["CA210181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19PRE34380436"],"award-info":[{"award-number":["19PRE34380436"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2019,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TGF\u03b2 is important during pancreatic ductal adenocarcinoma (PDA) progression. Canonical TGF\u03b2 signaling suppresses epithelial pancreatic cancer cell proliferation; as a result, inhibiting TGF\u03b2 has not been successful in PDA. In contrast, we demonstrate that inhibition of stromal TGF\u03b2R2 reduces IL\u20106 production from cancer\u2010associated fibroblasts, resulting in a reduction of STAT3 activation in tumor cells and reversion of the immunosuppressive landscape. Up to 7% of human PDA have tumor cell\u2010specific deficiency in canonical TGF\u03b2 signaling via loss of TGF\u03b2R2. We demonstrate that in PDA that harbors epithelial loss of TGF\u03b2R2, inhibition of TGF\u03b2 signaling is selective for stromal cells and results in a therapeutic benefit. Our study highlights the potential benefit of TGF\u03b2 blockade in PDA and the importance of stratifying PDA patients who might benefit from such therapy.<\/jats:p>","DOI":"10.15252\/emmm.201910515","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T06:03:30Z","timestamp":1571033010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Targeting TGF\u03b2R2\u2010mutant tumors exposes vulnerabilities to stromal TGF\u03b2 blockade in pancreatic cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6345-4566","authenticated-orcid":false,"given":"Huocong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-5310","authenticated-orcid":false,"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Sorrelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Medhat","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Toombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriah","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel Nasser","family":"Hosein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwait Amod","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla E","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-2377","authenticated-orcid":false,"given":"Rolf A","family":"Brekken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"BFEMMM201910515_CR1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.celrep.2014.04.036","volume":"7","author":"J Albrengues","year":"2014","unstructured":"Albrengues J, Bourget I, Pons C, Butet V, Hofman P, Tartare\u2010Deckert S, Feral CC, Meneguzzi G, Gaggioli C (2014) LIF mediates proinvasive activation of stromal fibroblasts in cancer. Cell Rep 7: 1664\u20131678","journal-title":"Cell Rep"},{"key":"BFEMMM201910515_CR2","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1101\/gad.1478706","volume":"20","author":"N Bardeesy","year":"2006","unstructured":"Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D et\u00a0al (2006) Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 20: 3130\u20133146","journal-title":"Genes Dev"},{"key":"BFEMMM201910515_CR3","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-18-1955","volume":"25","author":"V Bernard","year":"2019","unstructured":"Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N et\u00a0al (2019) Single\u2010cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res 25: 2194\u20132205","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201910515_CR4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, Preall J, Tuveson DA (2019) IL1\u2010induced JAK\/STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov 9: 282\u2013301","journal-title":"Cancer Discov"},{"key":"BFEMMM201910515_CR5","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","volume":"71","author":"RB Corcoran","year":"2011","unstructured":"Corcoran RB, Contino G, Deshpande V, Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA, Bardeesy N (2011) STAT3 plays a critical role in KRAS\u2010induced pancreatic tumorigenesis. Cancer Res 71: 5020\u20135029","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2018.08.007","volume":"29","author":"M Curtis","year":"2019","unstructured":"Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, Helou Y, Batlle R, Liu X, Gutierrez N et\u00a0al (2019) Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis. Cell Metab 29: 141\u2013155 e9","journal-title":"Cell Metab"},{"key":"BFEMMM201910515_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David CJ, Massague J (2018) Contextual determinants of TGFbeta action in\u00a0development, immunity and cancer. Nat Rev Mol Cell Biol 19: 419\u2013435","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFEMMM201910515_CR8","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3389\/fimmu.2018.01865","volume":"9","author":"AM Dufour","year":"2018","unstructured":"Dufour AM, Alvarez M, Russo B, Chizzolini C (2018) Interleukin\u20106 and type\u2010I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin\u201017A in the presence of transforming growth factor\u2010beta 1. Front Immunol 9: 1865","journal-title":"Front Immunol"},{"key":"BFEMMM201910515_CR9","doi-asserted-by":"crossref","first-page":"12933","DOI":"10.1074\/jbc.274.18.12933","volume":"274","author":"O Eickelberg","year":"1999","unstructured":"Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, Roth M (1999) Transforming growth factor\u2010beta1 induces interleukin\u20106 expression via activating protein\u20101 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274: 12933\u201312938","journal-title":"J Biol Chem"},{"key":"BFEMMM201910515_CR10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS et\u00a0al (2019) Cross\u2010species single\u2010cell analysis of pancreatic ductal adenocarcinoma reveals antigen\u2010presenting cancer\u2010associated fibroblasts. Cancer Discov 9: 1102\u20131123","journal-title":"Cancer Discov"},{"key":"BFEMMM201910515_CR11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in\u00a0vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF\u2010beta, PGE2, and PAF. J Clin Invest 101: 890\u2013898","journal-title":"J Clin Invest"},{"key":"BFEMMM201910515_CR12","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA (2012) The\u00a0pancreas cancer microenvironment. Clin Cancer Res 18: 4266\u20134276","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201910515_CR13","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/0016-5085(93)91084-U","volume":"105","author":"H Friess","year":"1993","unstructured":"Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI, Korc M (1993) Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846\u20131856","journal-title":"Gastroenterology"},{"key":"BFEMMM201910515_CR14","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-03-564450","volume":"124","author":"D Gotthardt","year":"2014","unstructured":"Gotthardt D, Putz EM, Straka E, Kudweis P, Biaggio M, Poli V, Strobl B, Muller M, Sexl V (2014) Loss of STAT3 in murine NK cells enhances NK cell\u2010dependent tumor surveillance. Blood 124: 2370\u20132379","journal-title":"Blood"},{"key":"BFEMMM201910515_CR15","doi-asserted-by":"crossref","first-page":"e1257453","DOI":"10.1080\/2162402X.2016.1257453","volume":"6","author":"A de Gramont","year":"2017","unstructured":"de Gramont A, Faivre S, Raymond E (2017) Novel TGF\u2010beta inhibitors ready for prime time in onco\u2010immunology. Oncoimmunology 6: e1257453","journal-title":"Oncoimmunology"},{"key":"BFEMMM201910515_CR16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH et\u00a0al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350\u2013353","journal-title":"Science"},{"key":"BFEMMM201910515_CR17","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-12-0634","volume":"72","author":"AF Hezel","year":"2012","unstructured":"Hezel AF, Deshpande V, Zimmerman SM, Contino G, Alagesan B, O'Dell MR, Rivera LB, Harper J, Lonning S, Brekken RA et\u00a0al (2012) TGF\u2010beta and alphavbeta6 integrin act in a common pathway to suppress pancreatic cancer progression. Cancer Res 72: 4840\u20134845","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR18","doi-asserted-by":"crossref","unstructured":"Hosein AN, Huang H, Wang Z, Parmar K, Du W, Huang J, Maitra A, Olson E, Verma U, Brekken RA (2019) Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single\u2010cell resolution. JCI Insight 5: 129212","DOI":"10.1101\/539874"},{"key":"BFEMMM201910515_CR20","doi-asserted-by":"crossref","first-page":"23208","DOI":"10.1074\/jbc.M116.740605","volume":"291","author":"H Huang","year":"2016","unstructured":"Huang H, Svoboda RA, Lazenby AJ, Saowapa J, Chaika N, Ding K, Wheelock MJ, Johnson KR (2016) Up\u2010regulation of N\u2010cadherin by collagen I\u2010activated discoidin domain receptor 1 in pancreatic cancer requires the adaptor molecule Shc1. J Biol Chem 291: 23208\u201323223","journal-title":"J Biol Chem"},{"key":"BFEMMM201910515_CR21","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.leu.2401236","volume":"12","author":"WA Hudson","year":"1998","unstructured":"Hudson WA, Li Q, Le C, Kersey JH (1998) Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects. Leukemia 12: 2029\u20132033","journal-title":"Leukemia"},{"key":"BFEMMM201910515_CR22","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","volume":"20","author":"H Ijichi","year":"2006","unstructured":"Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, Fujitani S, Wright CV, Moses HL (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas\u2010specific blockade of transforming growth factor\u2010beta signaling in cooperation with active Kras expression. Genes Dev 20: 3147\u20133160","journal-title":"Genes Dev"},{"key":"BFEMMM201910515_CR23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial\u2010mesenchymal transition. J Clin Invest 119: 1420\u20131428","journal-title":"J Clin Invest"},{"key":"BFEMMM201910515_CR24","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.amjsurg.2007.05.004","volume":"194","author":"M Korc","year":"2007","unstructured":"Korc M (2007) Pancreatic cancer\u2010associated stroma production. Am J Surg 194: S84\u2013S86","journal-title":"Am J Surg"},{"key":"BFEMMM201910515_CR25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","volume":"11","author":"M Kortylewski","year":"2005","unstructured":"Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon\u2010Thomas S, Niu G, Kay H, Mule J, Kerr WG et\u00a0al (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11: 1314\u20131321","journal-title":"Nat Med"},{"key":"BFEMMM201910515_CR26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","volume":"19","author":"M Lesina","year":"2011","unstructured":"Lesina M, Kurkowski MU, Ludes K, Rose\u2010John S, Treiber M, Kloppel G, Yoshimura A, Reindl W, Sipos B, Akira S et\u00a0al (2011) Stat3\/Socs3 activation by IL\u20106 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19: 456\u2013469","journal-title":"Cancer Cell"},{"key":"BFEMMM201910515_CR27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio M, Sil S, Malagon\u2010Lopez J, Nieman LT, Misale S, Di Pilato M, Ebright RY, Karabacak MN, Kulkarni AS, Liu A et\u00a0al (2019) Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell 178: 160\u2013175 e27","journal-title":"Cell"},{"key":"BFEMMM201910515_CR28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R et\u00a0al (2018) TGFbeta attenuates tumour response to PD\u2010L1 blockade by contributing to exclusion of T cells. Nature 554: 544\u2013548","journal-title":"Nature"},{"key":"BFEMMM201910515_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13: 453\u2013461","journal-title":"Front Biosci"},{"key":"BFEMMM201910515_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J (2008) TGFbeta in cancer. Cell 134: 215\u2013230","journal-title":"Cell"},{"key":"BFEMMM201910515_CR31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13: 616\u2013630","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFEMMM201910515_CR32","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1053\/j.gastro.2015.07.058","volume":"149","author":"NS Nagathihalli","year":"2015","unstructured":"Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL et\u00a0al (2015) Signal transducer and activator of transcription 3, mediated remodeling of the tumor microenvironment results in enhanced tumor drug delivery in a mouse model of pancreatic cancer. Gastroenterology 149: 1932\u20131943 e9","journal-title":"Gastroenterology"},{"key":"BFEMMM201910515_CR33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D Ohlund","year":"2017","unstructured":"Ohlund D, Handly\u2010Santana A, Biffi G, Elyada E, Almeida AS, Ponz\u2010Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ et\u00a0al (2017) Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med 214: 579\u2013596","journal-title":"J Exp Med"},{"key":"BFEMMM201910515_CR34","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1158\/0008-5472.CAN-13-1807","volume":"74","author":"KT Ostapoff","year":"2014","unstructured":"Ostapoff KT, Cenik BK, Wang M, Ye R, Xu X, Nugent D, Hagopian MM, Topalovski M, Rivera LB, Carroll KD et\u00a0al (2014) Neutralizing murine TGFbetaR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer Res 74: 4996\u20135007","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir BC, Pentcheva\u2010Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV et\u00a0al (2014) Depletion of carcinoma\u2010associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25: 719\u2013734","journal-title":"Cancer Cell"},{"key":"BFEMMM201910515_CR36","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/0008-5472.CAN-15-1293","volume":"76","author":"DR Principe","year":"2016","unstructured":"Principe DR, DeCant B, Mascarinas E, Wayne EA, Diaz AM, Akagi N, Hwang R, Pasche B, Dawson DW, Fang D et\u00a0al (2016) TGFbeta signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis. Cancer Res 76: 2525\u20132539","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR37","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74: 2913\u20132921","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW et\u00a0al (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25: 735\u2013747","journal-title":"Cancer Cell"},{"key":"BFEMMM201910515_CR39","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.4049\/jimmunol.136.10.3916","volume":"136","author":"AH Rook","year":"1986","unstructured":"Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS (1986) Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136: 3916\u20133920","journal-title":"J Immunol"},{"key":"BFEMMM201910515_CR40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/leu.2015.327","volume":"30","author":"RH Rouce","year":"2016","unstructured":"Rouce RH, Shaim H, Sekine T, Weber G, Ballard B, Ku S, Barese C, Murali V, Wu MF, Liu H et\u00a0al (2016) The TGF\u2010beta\/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B\u2010acute lymphoblastic leukemia. Leukemia 30: 800\u2013811","journal-title":"Leukemia"},{"key":"BFEMMM201910515_CR41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jtho.2016.05.025","volume":"11","author":"Y Shintani","year":"2016","unstructured":"Shintani Y, Fujiwara A, Kimura T, Kawamura T, Funaki S, Minami M, Okumura M (2016) IL\u20106 secreted from cancer\u2010associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial\u2010mesenchymal transition signaling. J Thorac Oncol 11: 1482\u20131492","journal-title":"J Thorac Oncol"},{"key":"BFEMMM201910515_CR42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4049\/jimmunol.1800878","volume":"202","author":"N Sorrelle","year":"2019","unstructured":"Sorrelle N, Ganguly D, Dominguez ATA, Zhang Y, Huang H, Dahal LN, Burton N, Ziemys A, Brekken RA (2019) Improved multiplex immunohistochemistry for immune microenvironment evaluation of mouse formalin\u2010fixed, paraffin\u2010embedded tissues. J Immunol 202: 292\u2013299","journal-title":"J Immunol"},{"key":"BFEMMM201910515_CR43","first-page":"4115","volume":"7","author":"M Tascilar","year":"2001","unstructured":"Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE et\u00a0al (2001) The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7: 4115\u20134121","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201910515_CR44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello DVF, Palomo\u2010Ponce S, Stork D, Berenguer\u2010Llergo A, Badia\u2010Ramentol J, Iglesias M, Sevillano M, Ibiza S, Canellas A, Hernando\u2010Momblona X et\u00a0al (2018) TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554: 538\u2013543","journal-title":"Nature"},{"key":"BFEMMM201910515_CR45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas DA, Massague J (2005) TGF\u2010beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8: 369\u2013380","journal-title":"Cancer Cell"},{"key":"BFEMMM201910515_CR46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000108959","volume":"7","author":"MJ Truty","year":"2007","unstructured":"Truty MJ, Urrutia R (2007) Basics of TGF\u2010beta and pancreatic cancer. Pancreatology 7: 423\u2013435","journal-title":"Pancreatology"},{"key":"BFEMMM201910515_CR47","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","volume":"9","author":"S Viel","year":"2016","unstructured":"Viel S, Marcais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E et\u00a0al (2016) TGF\u2010beta inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal 9: ra19","journal-title":"Sci Signal"},{"key":"BFEMMM201910515_CR48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K et\u00a0al (2015) Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518: 495\u2013501","journal-title":"Nature"},{"key":"BFEMMM201910515_CR49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu J, Lamouille S, Derynck R (2009) TGF\u2010beta\u2010induced epithelial to mesenchymal transition. Cell Res 19: 156\u2013172","journal-title":"Cell Res"},{"key":"BFEMMM201910515_CR50","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.18632\/oncotarget.23795","volume":"9","author":"JM Yingling","year":"2018","unstructured":"Yingling JM, McMillen WT, Yan L, Huang H, Sawyer JS, Graff J, Clawson DK, Britt KS, Anderson BD, Beight DW et\u00a0al (2018) Preclinical assessment of galunisertib (LY2157299 monohydrate), a first\u2010in\u2010class transforming growth factor\u2010beta receptor type I inhibitor. Oncotarget 9: 6659\u20136677","journal-title":"Oncotarget"},{"key":"BFEMMM201910515_CR51","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798\u2013809","journal-title":"Nat Rev Cancer"},{"key":"BFEMMM201910515_CR52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE (2009) Non\u2010Smad pathways in TGF\u2010beta signaling. Cell Res 19: 128\u2013139","journal-title":"Cell Res"},{"key":"BFEMMM201910515_CR53","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","volume":"73","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP (2013) Interleukin\u20106 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 73: 6359\u20136374","journal-title":"Cancer Res"},{"key":"BFEMMM201910515_CR54","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/1078-0432.CCR-09-1634","volume":"16","author":"ZJ Zhong","year":"2010","unstructured":"Zhong ZJ, Carroll KD, Policarpio D, Osborn C, Gregory M, Bassi R, Jimenez X, Prewett M, Liebisch G, Persaud K et\u00a0al (2010) Anti\u2010transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Clin Cancer Res 16: 1191\u20131205","journal-title":"Clin Cancer Res"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201910515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201910515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201910515\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201910515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201910515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:27:33Z","timestamp":1779085653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201910515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,7]]}},"alternative-id":["BFEMMM201910515"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201910515","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RAB reports receiving a commercial research grant from Eli Lilly & Company. KED is an employee of Eli Lilly and Company. The authors have no additional financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM201910515"}}